Acknowledgement
This study was funded by the Ministry of Health and Welfare of South Korea (HB16C0044, NHN2311070) and the Korea Institute of Oriental Medicine (KSN1823130).
References
- Weidner WS, Barbarino P. P4-443: THE STATE OF THE ART OF DEMENTIA RESEARCH: NEW FRONTIERS. Alzheimer's & Dementia. 2019;15(7S_Part_28):1473.
- O'Bryant SE, Lacritz LH, Hall J, Waring SC, Chan W, Khodr ZG, et al. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database. Arch Neurol. 2010;67:746-9. https://doi.org/10.1001/archneurol.2010.115
- McDougall F, Edgar C, Mertes M, Delmar P, Fontoura P, Abi-Saab D, et al. Psychometric properties of the clinical dementia rating - sum of boxes and other cognitive and functional outcomes in a prodromal alzheimer's disease population. J Prev Alzheimers Dis. 2021;8:151-60.
- Thoits T, Dutkiewicz A, Raguckas S, Lawrence M, Parker J, Keeley J, et al. Association between dementia severity and recommended lifestyle changes: a retrospective cohort study. Am J Alzheimers Dis Other Demen. 2018;33: 242-6. https://doi.org/10.1177/1533317518758785
- O'Malley AS, Rich EC, Maccarone A, DesRoches CM, Reid RJ. Disentangling the linkage of primary care features to patient outcomes: a review of current literature, data sources, and measurement needs. J Gen Intern Med. 2015;30 Suppl 3:S576-85. https://doi.org/10.1007/s11606-015-3311-9
- Petersen RC. Clinical practice. Mild cognitive impairment. N Engl J Med. 2011;364:2227-34. https://doi.org/10.1056/NEJMcp0910237
- Shirwaikar A, Govindarajan R, Rawat AK. Integrating com - plementary and alternative medicine with primary health care. Evid Based Complement Alternat Med. 2013;2013: 948308.
- Birch S, Alraek T, Bovey M, Lee MS, Lee JA, Zaslawski C, et al. Overview on pattern identification - History, nature and strategies for treating patients: A narrative review. European Journal of Integrative Medicine. 2020;35: 101101.
- The Textbook Compilation Committee of Neuropsychiatry of Korean Medical Schools in Nation. Third edition: The Neuropsychiatry of Oriental medicine. Seoul:JipmoonDong.; 2016. 319-27 p.
- J H. Donguibogam: Seoul:Namsandang; 2007.
- Shi J, Tian J, Long Z, Liu X, Wei M, Ni J, et al. The Pattern element scale: a brief tool of traditional medical subtyping for dementia. Evidence-Based Complementary and Alternative Medicine. 2013;2013:460562.
- Go eun L, Kwang Su M, Nam Kwen K, Chung sun y, In Chul J, Hyung Won K. Preliminary Study to Develop the Korean Medical Pathologic Aging Scale and Korean Medical Pattern Identification for Dementia. The Journal of Korean Medicine. 2017;38(3):111-23. https://doi.org/10.13048/jkm.17030
- Ji-yoon Lee HK, Young Kyung Seo, Hyung Won Kang*, Kang*, Wee-Chang Kang, In Chul Jung. A research to evaluate the reliability and validity of pattern identifications tool for cognitive disorder: a clinical study protocol. J of Oriental Neuropsychiatry. 2018;29:255-66.
- Cho JH, Oh DS, Hong SH, Ko H, Lee NH, Park SE, et al. A nationwide study of the incidence rate of herb-induced liver injury in Korea. Arch Toxicol. 2017;91:4009-15. https://doi.org/10.1007/s00204-017-2007-9
- Geun-yeob Kim G-tK, Ho-yeon Go, Heung Ko, Seon-mi Shin. A case report of liver and renal function changes in stroke patients taking long-term herbal medicine. The Journal of Internal Korean Medicine 2017;38:555-63. https://doi.org/10.22246/jikm.2017.38.5.555
- Herholz K, Haense C, Gerhard A, Jones M, Anton-Rodriguez J, Segobin S, et al. Metabolic regional and network changes in Alzheimer's disease subtypes. J Cereb Blood Flow Metab. 2018;38:1796-806. https://doi.org/10.1177/0271678X17718436
- Fillit H, Nash DT, Rundek T, Zuckerman A. Cardiovascular risk factors and dementia. Am J Geriatr Pharmacother. 2008;6:100-18. https://doi.org/10.1016/j.amjopharm.2008.06.004
- Santos CY, Snyder PJ, Wu WC, Zhang M, Echeverria A, Alber J. Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. Alzheimers Dement (Amst). 2017;7:69-87. https://doi.org/10.1016/j.dadm.2017.01.005
- Le Couteur DG, Blyth FM, Creasey HM, Handelsman DJ, Naganathan V, Sambrook PN, et al. The association of alanine transaminase with aging, frailty, and mortality. J Gerontol A Biol Sci Med Sci. 2010;65:712-7. https://doi.org/10.1093/gerona/glq082
- Lu Y, Pike JR, Selvin E, Mosley T, Palta P, Sharrett AR, et al. Low liver enzymes and risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study. J Alzheimers Dis. 2021;79:1775-84. https://doi.org/10.3233/JAD-201241
- Jeong JH, Lee JY, Kim JY, Seo YK, Kang WC, Kang HW, et al. Safety and efficacy of Jujadokseo-hwan for memory deficit (amnesia) in mild neurocognitive disorder: A protocol for randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial. Medicine. 2020; 99:e19231.
- Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-72. https://doi.org/10.1192/bjp.140.6.566
- Lynch CA, Walsh C, Blanco A, Moran M, Coen RF, Walsh JB, et al. The clinical dementia rating sum of box score in mild dementia. Dement Geriatr Cogn Disord. 2006;21: 40-3. https://doi.org/10.1159/000089218
- Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-4. https://doi.org/10.1212/WNL.43.11.2412-a
- Miao Y, Tian J, Shi J, Mao M, Zhao X, Fang L, et al. Correlation between cognitive functions and syndromes of traditional Chinese medicine in amnestic mild cognitive impairment. Zhong xi yi jie he xue bao= Journal of Chinese Integrative Medicine. 2009;7:205-11. https://doi.org/10.3736/jcim20090302
- Miao YC, Tian JZ, Shi J, Mao M. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial. Zhong Xi Yi Jie He Xue Bao. 2012;10: 390-7. https://doi.org/10.3736/jcim20120407
- Liu J, Wang L-n, Tian J-z. Recognition of dementia in ancient China. Neurobiology of aging. 2012;33:2948. e11-.e13.
- Lim HS, Kim YJ, Sohn E, Yoon J, Kim BY, Jeong SJ. Bojungikgi-Tang, a traditional herbal formula, exerts neuroprotective effects and ameliorates memory impairments in alzheimer's disease-like experimental models. Nutrients. 2018;10.
- Fu C, Zhang NL, Chen BX, Chen ZR, Jin XL, Guo RJ, et al. Identification and classification of traditional Chinese medicine syndrome types among senior patients with vascular mild cognitive impairment using latent tree analysis. J Integr Med. 2017;15:186-200. https://doi.org/10.1016/S2095-4964(17)60335-2
- Tang NY, Liu CH, Liu HJ, Li TC, Liu JC, Chen PK, et al. Chinese medicine patterns in patients with post-stroke dementia. J Tradit Complement Med. 2012;2:123-8. https://doi.org/10.1016/S2225-4110(16)30085-2
- Tian JZ, Shi J, Ni JN, Wei MQ, Zhang XK, Chen KJ, et al. Sequential therapy based on evolvement of patterns: a new model for treatment of alzheimer's disease. Chin J Integr Med. 2019;25:565-73. https://doi.org/10.1007/s11655-019-3066-y
- Cummings J, Hahn-Pedersen JH, Eichinger CS, Freeman C, Clark A, Tarazona LRS, Lanctot K. Exploring the relationship between patient-relevant outcomes and Alzheimer's disease progression assessed using the clinical dementia rating scale: a systematic literature review. Front Neurol. 2023;17:1208802.
- Bae H, Lee S, Lee CY, Kim CE. A novel framework for understanding the pattern identification of traditional asian medicine from the machine learning perspective. Front Med (Lausanne). 2021;8:763533.
- Choi Y, Kim Y-E, Jerng UM, Kim H, Lee SI, Kim GN, et al. Korean traditional medicine in treating patients with mild cognitive impairment: a multicenter prospective observational case series. Evidence-Based Complementary and Alternative Medicine. 2020;22:4323989.
- Nho K, Kueider-Paisley A, Ahmad S, MahmoudianDehkordi S, Arnold M, Risacher SL, et al. Association of altered liver enzymes with alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers. JAMA Netw Open. 2019;2:e197978.
- Parsons CG, Danysz W, Quack G. Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect. 1998;11:523-69. https://doi.org/10.1358/dnp.1998.11.9.863689
- Cassano T, Pace L, Bedse G, Lavecchia AM, De Marco F, Gaetani S, et al. Glutamate and mitochondria: two prom - inent players in the oxidative stress-induced neurodegeneration. Curr Alzheimer Res. 2016;13:185-97. https://doi.org/10.2174/1567205013666151218132725
- Pietzner M, Budde K, Homuth G, Kastenmuller G, Henning AK, Artati A, et al. Hepatic steatosis is associated with adverse molecular signatures in subjects without diabetes. J Clin Endocrinol Metab. 2018;103:3856-68. https://doi.org/10.1210/jc.2018-00999
- Kapogiannis D, Mattson MP. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol. 2011;10: 187-98. https://doi.org/10.1016/S1474-4422(10)70277-5
- Qian K, Zhong S, Xie K, Yu D, Yang R, Gong DW. Hepatic ALT isoenzymes are elevated in gluconeogenic conditions including diabetes and suppressed by insulin at the protein level. Diabetes Metab Res Rev. 2015;31:562-71. https://doi.org/10.1002/dmrr.2655
- Wu K, Xu C, Qiu G, Guo Q, Chen C, Liu W, et al. Association of lower liver function with cognitive impairment in the Shenzhen ageing-related disorder cohort in China. Front Aging Neurosci. 2022;14:1012219.